109 related articles for article (PubMed ID: 11823959)
1. Acanthosis nigricans: a new manifestation of insulin resistance in patients receiving treatment with protease inhibitors.
Mellor-Pita S; Yebra-Bango M; Alfaro-Martínez J; Suárez E
Clin Infect Dis; 2002 Mar; 34(5):716-7. PubMed ID: 11823959
[No Abstract] [Full Text] [Related]
2. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
[TBL] [Abstract][Full Text] [Related]
3. Acanthosis nigricans and hyperandrogenism in a pregnancy complicated by diabetes.
Gemer O; Segal S; Segal O; Zohav E; Sassoon E
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):810-1. PubMed ID: 8469481
[TBL] [Abstract][Full Text] [Related]
4. Editorial comment: boosted PIs and metabolism--it's not just the ritonavir.
Moyle GJ
AIDS Read; 2005 Oct; 15(10):531. PubMed ID: 16265769
[No Abstract] [Full Text] [Related]
5. [Diabetes, insulin resistance and HIV].
Vallejo O
Sidahora; 2004; (1):22-5. PubMed ID: 15551439
[No Abstract] [Full Text] [Related]
6. [Will acanthosis nigricans be a new cutaneous manifestation of human immunodeficiency virus infection?].
Maltez F; Martins T; Morgado A; Proença R
Acta Med Port; 1997; 10(6-7):493-5. PubMed ID: 9341043
[TBL] [Abstract][Full Text] [Related]
7. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C
Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762
[No Abstract] [Full Text] [Related]
8. Exogenous insulin-derived acanthosis nigricans: could it be a cause of increased insulin requirement?
Dhingra M; Garg G; Gupta M; Khurana U; Thami GP
Dermatol Online J; 2013 Jan; 19(1):9. PubMed ID: 23374951
[TBL] [Abstract][Full Text] [Related]
9. AACTG recommendations for metabolic problems. Guide covers insulin resistance and diabetes.
AIDS Alert; 2003 Jan; 18(1):6. PubMed ID: 12541993
[TBL] [Abstract][Full Text] [Related]
10. Hair loss in an HIV-1 infected woman receiving lopinavir plus ritonavir therapy as first line HAART.
Bongiovanni M; Chiesa E; Monforte Ad; Bini T
Dermatol Online J; 2003 Dec; 9(5):28. PubMed ID: 14996401
[No Abstract] [Full Text] [Related]
11. Fatal lactic acidosis during antiretroviral therapy.
Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
[TBL] [Abstract][Full Text] [Related]
12. Acute hepatitis in HIV-infected patients during ritonavir treatment.
Arribas JR; Ibáñez C; Ruiz-Antoran B; Peña JM; Esteban-Calvo C; Frías J; Vázquez JJ; González-García JJ
AIDS; 1998 Sep; 12(13):1722-4. PubMed ID: 9764797
[No Abstract] [Full Text] [Related]
13. Ritonavir-boosted protease inhibitors: impact of ritonavir on toxicities in treatment-experienced patients.
Sension M; Piliero PJ
J Assoc Nurses AIDS Care; 2007; 18(1):36-47. PubMed ID: 17338984
[TBL] [Abstract][Full Text] [Related]
14. The syndrome of insulin resistance, acanthosis nigricans and an autoimmune disorder in diabetes mellitus treated with immunosuppressants.
Richards R; Morrison EY
West Indian Med J; 1984 Sep; 33(3):195-7. PubMed ID: 6495719
[No Abstract] [Full Text] [Related]
15. Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.
Martínez E; Domingo P; Galindo MJ; Milinkovic A; Arroyo JA; Baldovi F; Larrousse M; León A; de Lazzari E; Gatell JM
Clin Infect Dis; 2004 Apr; 38(7):1017-23. PubMed ID: 15034836
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
18. Hyponatraemia associated with lopinavir--ritonavir?
Roberts MT; Aliyu SH
Int J Infect Dis; 2007 Jan; 11(1):83-4. PubMed ID: 16574455
[No Abstract] [Full Text] [Related]
19. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
[TBL] [Abstract][Full Text] [Related]
20. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
Copeland K; Pankratz K; Cathey V; Immohotichey P; Maddox J; Felton B; McIntosh R; Parker D; Burgin C; Blackett P
J Okla State Med Assoc; 2006 Jan; 99(1):19-24. PubMed ID: 16499154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
